BURNSURGERY.ORG 

Educating the burn care professionals around the world

Search Site  

 

Orders in Burn Care

 

Chapter 4: Allergies

 

ALLERGIES: _______________________________________________

 

I.   Significance

A.     A history of an allergy to a vital drug could be a death

            sentence.

B.    The major allergies encountered in burn care are to b-lactam antibiotics and sulfa drugs.

 

 

II. History

A.    Patients stating any allergic history must be taken

seriously and penicillin should be held pending further investigations.

B.    An accurate history of the specific reaction elicited is

important.

C.    You need to distinguish between:

1.   A true allergic reaction which is anaphylaxis (i.e. hypotension, laryngeal edema, bronchospasm) and cutaneous reactions

             2.   Nonspecific symptoms (i.e. headache, nausea, emesis).

 

 

III.  Penicillin allergy

A.      Penicillin allergy is the most prevalent immunological drug reaction in clinical medicine. IgE antibodies directed against the b-lactam ring are responsible for the type 1 reaction seen.  If a patient gives a history of an urticarial rash and bronchospasm the diagnosis of penicillin allergy is made. Though penicillin allergies are often diagnosed in childhood, studies of this age group show that over-diagnosis of penicillin allergy may occur in up to 94% of cases.[i]  Penicillin is regarded as the most important antimicrobial agent in greatly reducing hemolytic streptococcal and clostridial infections, and is often used to treat burn cellulitis.

 

B.          Can we use cephalosporins?

1.          The overall incidence of adverse reactions from cephalosporins ranges from 1% to 10%, with rare anaphylaxis (< 0.02%). Post-marketing studies of second and third generation cephalosporins showed no increase in allergic reactions in patients with a history of penicillin allergy.  Similarly, patients with cephalosporin allergies have a very small risk of penicillin reactions.

 

2.          A patient who states he or she has a history of rash to penicillin can be treated instead with a first generation cephalosporin.  Patients with anaphylactic reactions to penicillin should receive neither penicillin nor cephalosporin.  These patients can be treated with vancomycin and penicillin desensitization in conjunction with recommendations by an infectious disease specialist. Intravenous desensitization is a rapid, safe, and effective technique for patients demonstrating hypersensitivity to beta-lactam antibiotics who require therapy with these medications.[ii],[iii]

 

3.          Penicillin skin tests are not used, as they do not predict the likelihood of allergic reactions to cephalosporins in patients with histories of penicillin allergy. [iv]

 

4.          RAST is a solid-phase sandwich radioimmunoassay to detect allergen-specific IgE antibodies.  The AlaSTAT test is an enzymoimmunoassay alternative to the RAST that is more rapid.  Neither of these is commonly used in confirming drug allergies.

 

 

C.                Sulfa allergies

Allergies to silver sulfadiazine and mafenide acetate, the two topical agents used most widely in burn therapy today, have been reported.[v],[vi],[vii],[viii],[ix]  The reactions are usually mild.  Serious hypersensitivity to these agents has been rarely described.[x],[xi]   Only 2 to 5 percent of patients treated with silvadine cream exhibit a minor maculopapular rash that rarely requires discontinuation of the agent, and 5 to 50 percent of patients treated with mafenide acetate develop a rash that is easily controlled with antihistamines and also does not require discontinuation.9,10,11 



[i] Graff-Lonnevig V, et al, Penicillin allergy -  A rare pediatric condition?  Arch Dis Child 1988;63:  1342-6.

[ii] Borish L. Tamir R. Rosenwasser LJ. Intravenous desensitization to beta-lactam antibiotics. Journal of Allergy & Clinical Immunology. 80(3 Pt 1):314-9, 1987 Sep.

[iii] Stark BJ. Earl HS. Gross GN. Lumry WR. Goodman EL. Sullivan TJ. Acute and chronic desensitization of penicillin-allergic patients using oral penicillin. Journal of Allergy & Clinical Immunology. 79(3):523-32, 1987 Mar.

[iv] Anne S, Reisman RE. Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy. Ann Allergy Asthma Immunol 1995; 74: 167-70.

[v] Dodd D, Stutman HR.  Current issues in burn wound infections.  Adv Pediatr Infect Dis 1991; 6:137-162.

[vi] Hoffman S.  Silver sulfadiazine:  an antibacterial agent for topical use in burns.  Scand J Plast Reconstr Surg 1984;18:119-126.

[vii] Monafo WW, Freedman B.  Topical therapy for burns.  Surg Clin North Am 1987;67:133-145.

[viii] Monafo WW, West MA.  Current treatment recommendations for topical burn therapy.  Drugs  1990;  40:364-373.

[ix] Taddonio TE, Thompson PD, Smith DJ, Prasad JK.  A survey of wound monitoring and topical antimicrobial therapy practices in the treatment of burn injury.  J Burn Care Rehabil 1990;11:423-427.

[x] McKenna DR, Latenser LM, Jones LM, Barrette RR, Sherman HF, Varcelotti JR.  Serious silver sulphadiazine and mafenide acetate dermatitis.  Burns 21(4):310-2, 1995 Jun.

[xi] Fraser-Moodie A.  Sensitivity to silver in a patient treated with silver sulphadiazine (Flamazine).  Burns 18(1):74-5, 1992 Feb.

 

 


© Copyright 2002 Burnsurgery.org. All Rights Reserved